Interventional Radiology Products Market Trends

ID: MRFR/HC/10026-HCR

200 Pages

Rahul Gotadki

February 2026

Global Interventional Radiology Products Market Research Report: Size, Share, Trend Analysis By Product Type (Catheters, Guide Wires, Embolic Agents, Radiology Visualization Systems, Ablation Devices), By Procedure Type (Angiography, Biliary Interventions, Biopsy, Drainage Procedures, Ablation), By End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers), By Applications (Oncology, Cardiology, Urology, Neurology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East, and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Interventional Radiology Products Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Interventional Radiology Products Market

There has been an observable trend, in the interventional radiology products market, demonstrating the shift in medical imaging and minimally invasive procedures. This includes but is not limited to a number of product types that are used in interventional radiology which is a discipline of medicine that uses images as guides for diagnosis or treatment. The Interventional Radiology Products Market has undergone significant transformations over the past few years, driven by technological change, increasing preference for non-invasive procedures and escalating demand for precision and speed in medical processes.

One major trend within the Interventional Radiology Products Market is the application of high-resolution imaging technologies during operations. For instance, with fluoroscopy, ultrasound machine as well as computed tomography (CT), intervention radiologists have been able to visualize and man oeuvre within human body more accurately compared to before. Besides making interventions safer and more effective than ever before this trend also makes possible minimally invasive methods for performing many other procedures.

In regard to interventional radiology applications, there has been a rise in minimal invasion techniques where incisions are smaller and there is less damage on surrounding tissues. It originates from patients fearing pain, allowing them to be treated faster with lower costs than could be incurred if it were otherwise. Such minimal invasion approaches depend heavily on interventional radiology devices like catheters or guidewires plus embolic agents among others products introduced into this sector by manufacturers. The market sees an increasing need for devices enabling an exact path through which drugs can be injected thus fueling growth of miniaturized surgeries.

Another important development within the Interventional Radiology Products Market is robotics and artificial intelligence (AI) being integrated into interventional practices. For example, robotics help doctors improve precision levels when using instruments thereby making it easier to handle complex procedures successfully. Moreover, AI algorithms on image analyzing facilitate diagnostics and treatment planning too. Consequently, these advanced systems are integrated into various products employed in interventional radiology and these are the most important steps in improving personalized and efficient patient care.

In addition, there is a shift towards ambulatory care and outpatient settings for the delivery of interventional radiology. Technology advancements together with low invasiveness seen in most interventions have made it possible to perform procedures on patients that do not require them to stay at the hospital for long periods. This aligns with wider healthcare objectives aimed at decreasing admissions, making services more convenient for patients and better utilization of resources. Outpatient oriented interventional radiology products are increasingly being embraced hence boosting market expansion.

Moreover, an emerging trend is the development of specialized interventional products tailored to specific medical conditions. In line with expanding range of intervention procedures, manufacturers now create specific devices for different maladies. A case in point is products meant for vascular interventions, oncology as well as neuro-interventions etc. As such, there is an increased availability of disease-specific interventional radiological products which enable medical practitioners choose instruments that suit their patients’ needs.

Innovation in Interventional Radiology Products Market comes from collaborations between industry players and healthcare institutions. This creates room for knowledge transfer, resource sharing as well as skill acquisition necessary in inventing new generation goods. There has been a great deal of synergy between manufacturers, researchers and clinicians leading to immediate commercialization of scientific breakthroughs related to new interventional radiology tools.

However, a few difficulties still persist in the market including standardizing training programs for medical professionals and dealing with radiation exposure arising from certain interventional procedures. Furthermore, making sure advanced interventional radiology products are affordable and accessible is an ongoing puzzle in the industry especially to developing nations.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected market valuation of the Interventional Radiology Products Market by 2035?

The projected market valuation for the Interventional Radiology Products Market is 52.73 USD Billion by 2035.

What was the market valuation of the Interventional Radiology Products Market in 2024?

The overall market valuation of the Interventional Radiology Products Market was 28.35 USD Billion in 2024.

What is the expected CAGR for the Interventional Radiology Products Market during the forecast period 2025 - 2035?

The expected CAGR for the Interventional Radiology Products Market during the forecast period 2025 - 2035 is 5.8%.

Which product type segment is projected to have the highest valuation by 2035?

The Catheters segment is projected to reach a valuation of 15.5 USD Billion by 2035.

What are the key players in the Interventional Radiology Products Market?

Key players in the market include Medtronic, Boston Scientific, Johnson & Johnson, Siemens Healthineers, Bayer, Cook Medical, Terumo Corporation, Philips, and Stryker Corporation.

Which end user segment is expected to grow the most by 2035?

The Hospitals segment is expected to grow to a valuation of 20.0 USD Billion by 2035.

What is the projected valuation for the Ablation Devices segment by 2035?

The Ablation Devices segment is projected to reach a valuation of 10.73 USD Billion by 2035.

How does the projected valuation for the Angiography segment compare to the Biliary Interventions segment by 2035?

The Angiography segment is projected to reach 15.5 USD Billion, whereas the Biliary Interventions segment is expected to reach 9.0 USD Billion by 2035.

What application segment is anticipated to have the highest growth by 2035?

The Oncology application segment is anticipated to grow to a valuation of 15.5 USD Billion by 2035.

What is the projected valuation for the Diagnostic Imaging Centers end user segment by 2035?

The Diagnostic Imaging Centers end user segment is projected to reach a valuation of 17.73 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future analysis, the Interventional Radiology Products Market was estimated at 28.35 USD Billion in 2024. The Interventional Radiology Products industry is projected to grow from 30.0 USD Billion in 2025 to 52.73 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Interventional Radiology Products Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

Technological advancements are reshaping the Interventional Radiology Products Market, enhancing procedural efficacy and safety. North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for interventional radiology products. Catheters dominate the market as the largest segment, whereas ablation devices are witnessing the fastest growth due to rising procedural adoption. Key market drivers include technological innovations in imaging techniques and the increasing prevalence of chronic diseases, which are propelling demand for these products.

Interventional Radiology Products Market

CAGR

5.8%

Market Size & Forecast

2024 Market Size	28.35 (USD Billion)
2035 Market Size	52.73 (USD Billion)
CAGR (2025 - 2035)	5.8%
Largest Regional Market Share in 2024	North America

Major Players

Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), Siemens Healthineers (DE), Bayer (DE), Cook Medical (US), Terumo Corporation (JP), Philips (NL), Stryker Corporation (US)

Market Trends

The Interventional Radiology Products Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing demand for minimally invasive procedures. This market encompasses a wide array of products, including catheters, guidewires, and imaging systems, which are essential for various diagnostic and therapeutic interventions. As healthcare providers seek to enhance patient outcomes and reduce recovery times, the adoption of these innovative solutions appears to be on the rise. Furthermore, the growing prevalence of chronic diseases necessitates the development of more effective treatment options, thereby propelling the market forward. In addition, the Interventional Radiology Products Market is likely to benefit from ongoing research and development efforts aimed at improving existing products and creating new ones. Regulatory bodies are also playing a crucial role in ensuring the safety and efficacy of these devices, which may foster greater confidence among healthcare professionals. As the landscape evolves, collaboration between manufacturers, healthcare providers, and regulatory agencies seems essential for addressing emerging challenges and capitalizing on new opportunities. Overall, the market is poised for growth, driven by innovation and a commitment to enhancing patient care.

Technological Advancements

The Interventional Radiology Products Market is witnessing rapid technological advancements that enhance the precision and effectiveness of procedures. Innovations in imaging technologies, such as real-time imaging and 3D visualization, are improving the accuracy of interventions. These developments not only facilitate better outcomes but also contribute to the growing acceptance of interventional radiology among healthcare professionals.

Rising Demand for Minimally Invasive Procedures

There is a notable increase in the demand for minimally invasive procedures within the Interventional Radiology Products Market. Patients and healthcare providers alike are recognizing the benefits of these techniques, which often result in shorter recovery times and reduced hospital stays. This trend is likely to drive the adoption of interventional radiology products as more practitioners seek to offer these advanced treatment options.

Focus on Patient-Centric Solutions

The Interventional Radiology Products Market is increasingly focusing on patient-centric solutions that prioritize comfort and safety. Manufacturers are developing products that not only improve procedural efficiency but also enhance the overall patient experience. This shift towards patient-centered care is expected to influence product development and marketing strategies in the coming years.

Interventional Radiology Products Market Market Drivers

Growing Aging Population

The demographic shift towards an aging population is a crucial factor influencing the Interventional Radiology Products Market. As individuals age, they are more susceptible to various health issues, including vascular diseases and tumors, which often require interventional radiology interventions. The World Health Organization has indicated that the proportion of older adults is expected to rise significantly in the coming years, leading to an increased demand for healthcare services. Interventional radiology provides effective treatment options for age-related conditions, making it an attractive choice for healthcare providers. This demographic trend is likely to drive the adoption of interventional radiology products, as healthcare systems adapt to meet the needs of an older population. Consequently, the market is poised for growth as the demand for specialized interventional procedures escalates.

Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver for the Interventional Radiology Products Market. Governments and private entities are allocating substantial resources to enhance healthcare facilities, particularly in developing regions. This investment often includes the acquisition of advanced medical equipment, including interventional radiology products. Improved healthcare infrastructure not only increases access to interventional radiology services but also enhances the quality of care provided. As facilities upgrade their capabilities, the demand for interventional radiology procedures is likely to rise, further stimulating market growth. Additionally, the establishment of specialized centers for interventional radiology is becoming more common, which may lead to increased patient referrals and a higher volume of procedures performed. This trend indicates a positive outlook for the interventional radiology products market as healthcare systems evolve.

Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a pivotal driver for the Interventional Radiology Products Market. Conditions such as cardiovascular diseases, cancer, and diabetes are becoming more common, necessitating advanced treatment options. Interventional radiology offers minimally invasive solutions for managing these conditions, which are often preferred by patients due to shorter recovery times and reduced hospital stays. According to recent statistics, the incidence of chronic diseases is expected to increase significantly, leading to a higher demand for interventional procedures. This trend suggests that healthcare providers will increasingly rely on interventional radiology techniques to address the growing burden of chronic illnesses, thereby propelling the market forward. The expansion of treatment options available through interventional radiology is likely to enhance patient outcomes and satisfaction.

Technological Innovations in Imaging Techniques

The Interventional Radiology Products Market is experiencing a surge in technological innovations, particularly in imaging techniques. Advanced imaging modalities such as MRI, CT, and ultrasound are becoming increasingly sophisticated, allowing for enhanced visualization of vascular structures and lesions. This improvement in imaging technology facilitates more accurate diagnoses and treatment planning, which is crucial for interventional radiology procedures. The integration of artificial intelligence and machine learning into imaging systems is also noteworthy, as it aids in the interpretation of complex data. As a result, the demand for advanced imaging equipment is likely to rise, driving growth in the interventional radiology products market. Furthermore, the market for imaging systems is projected to reach substantial figures, indicating a robust trend towards innovation in this sector.

Rising Awareness and Acceptance of Minimally Invasive Procedures

There is a notable increase in awareness and acceptance of minimally invasive procedures among patients and healthcare professionals, which is positively impacting the Interventional Radiology Products Market. Patients are becoming more informed about the benefits of such procedures, including reduced pain, shorter recovery times, and lower risk of complications. This growing awareness is encouraging more individuals to opt for interventional radiology treatments over traditional surgical options. Additionally, healthcare providers are increasingly recognizing the advantages of these techniques, leading to a broader implementation of interventional radiology practices. As a result, the market for interventional radiology products is likely to expand, driven by the increasing preference for minimally invasive solutions. This trend suggests a shift in patient and provider attitudes towards embracing innovative treatment modalities.

Market Segment Insights

By Product Type: Catheters (Largest) vs. Ablation Devices (Fastest-Growing)

Within the Interventional Radiology Products Market, catheters dominate the product type segment, accounting for the largest share due to their essential role in minimally invasive procedures. Guide wires and embolic agents also contribute significantly, each holding substantial portions of the market. Radiology visualization systems and ablation devices are crucial as well, although they occupy lower market share positions compared to catheters. The demand for these products underscores the increasing reliance on interventional techniques in medical practices.

Catheters (Dominant) vs. Ablation Devices (Emerging)

Catheters are a vital component in interventional procedures, providing access to blood vessels and other anatomical structures, thus positioning them as the dominant product type in the market. Their established use in diagnostic and therapeutic interventions ensures sustained demand. On the other hand, ablation devices are emerging rapidly, driven by technological advancements and the rising prevalence of chronic diseases requiring minimally invasive treatments. Both segments cater to the evolving needs of healthcare professionals, with catheters offering reliability and ablation devices reflecting innovation in treatment methods.

By Procedure Type: Angiography (Largest) vs. Ablation (Fastest-Growing)

In the Interventional Radiology Products Market, the procedure type segment is led by angiography, which commands the largest market share. Biliary interventions, biopsy, drainage procedures, and ablation are also significant contributors, but they occupy smaller portions of the overall market. Angiography’s position is bolstered by its widespread application in various diagnostic and therapeutic contexts. Meanwhile, other procedures demonstrate notable market presence but are not as dominant as angiography.

Angiography (Dominant) vs. Ablation (Emerging)

Angiography has established itself as a dominant procedure type within the Interventional Radiology Products Market due to its essential role in diagnosing and treating vascular diseases. It relies on advanced imaging technologies to visualize the blood vessels, which supports a variety of therapeutic interventions. On the other hand, ablation has emerged as a rapidly growing technique, particularly in the treatment of tumors and cardiac rhythm disorders. The rising incidence of these conditions and the increasing adoption of minimally invasive techniques have positioned ablation as a promising area for growth in the market.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Interventional Radiology Products Market, hospitals show a substantial dominance, accounting for the largest share of the end-user segment. Their extensive capabilities for complex procedures and access to advanced technologies contribute to this significant share. Following them, ambulatory surgical centers are becoming increasingly relevant due to their convenience, efficiency, and cost-effectiveness, catering to patients who require less invasive interventions.

End Users: Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals remain at the forefront of the Interventional Radiology Products Market due to their comprehensive facilities, highly skilled professionals, and access to the latest technological advancements. The significant variety of patients requiring intervention necessitates a wide array of procedures, making hospitals a vital component of this market. In contrast, ambulatory surgical centers are rapidly gaining traction as they offer a more efficient, patient-friendly approach to surgical interventions. These centers capitalize on the trend towards outpatient procedures, enabling quicker recovery times and reduced healthcare costs, positioning them as a compelling alternative to traditional hospitals.

By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing)

The Interventional Radiology Products Market is characterized by its diverse applications, with oncology holding the largest market share. This segment significantly outweighs others such as cardiology, urology, and neurology, due to the increasing prevalence of cancer and the rising demand for minimally invasive procedures. Cardiology, while not the largest, represents a key area of growth with innovative technologies enhancing treatment outcomes. Growth trends within this segment are driven by advancements in product development and increasing adoption rates among healthcare providers. The emphasis on early detection and minimally invasive techniques is leading to broader utilization of interventional radiology in oncology. Meanwhile, cardiology is emerging as the fastest-growing segment due to the escalating incidence of heart diseases and the focus on integrated healthcare solutions.

Oncology (Dominant) vs. Urology (Emerging)

Oncology continues to be the dominant application in the Interventional Radiology Products Market, primarily due to the widespread cases of cancer that necessitate advanced treatment methods. This segment benefits from an array of innovative technologies that facilitate the diagnosis and treatment of tumors, which helps enhance patient outcomes and streamline clinical workflows. In contrast, urology is recognized as an emerging application area experiencing significant growth potential. The rise in urological conditions, coupled with enhanced imaging technologies, is propelling the adoption of interventional radiology in this field. Urology's focus on improving patient care through minimally invasive techniques and reduced recovery times positions it strategically within the market, leading to an increased interest from healthcare providers.

Get more detailed insights about Interventional Radiology Products Market Research Report-Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for interventional radiology products, accounting for approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and a strong emphasis on minimally invasive procedures. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies. The United States is the primary contributor, with significant investments from key players such as Medtronic, Boston Scientific, and Johnson & Johnson. The competitive landscape is characterized by rapid technological advancements and a focus on improving patient outcomes. Canada also plays a vital role, contributing to the overall market growth with its robust healthcare system and increasing demand for interventional procedures.

Europe : Emerging Market with Growth Potential

Europe is the second-largest market for interventional radiology products, holding approximately 30% of the global market share. The region is witnessing growth due to an aging population, rising healthcare expenditure, and increasing awareness of minimally invasive procedures. Regulatory frameworks, such as the Medical Device Regulation (MDR), are enhancing product safety and efficacy, thereby boosting market confidence. Leading countries include Germany, France, and the UK, where major players like Siemens Healthineers and Bayer are actively involved. The competitive landscape is evolving, with a focus on innovation and strategic partnerships. The presence of advanced healthcare facilities and a strong emphasis on research and development further contribute to the region's market dynamics.

Asia-Pacific : Rapidly Growing Market Segment

Asia-Pacific is an emerging powerhouse in the interventional radiology products market, accounting for about 20% of the global share. The region's growth is propelled by increasing healthcare investments, a rising prevalence of lifestyle-related diseases, and a growing demand for advanced medical technologies. Countries like China and India are witnessing significant improvements in healthcare infrastructure, which is further driving market expansion. China is the largest market in the region, followed by Japan and India, where local and international players are increasingly collaborating to enhance product offerings. The competitive landscape is marked by a mix of established companies and new entrants, focusing on innovation and affordability to cater to the diverse needs of the population. The presence of key players like Terumo Corporation and Philips strengthens the market further.

Middle East and Africa : Untapped Potential in Healthcare

The Middle East and Africa region is gradually emerging in the interventional radiology products market, holding approximately 5% of the global share. The growth is driven by increasing healthcare investments, a rising prevalence of chronic diseases, and a growing awareness of advanced medical technologies. Governments are focusing on improving healthcare infrastructure, which is expected to catalyze market growth in the coming years. Countries like the UAE and South Africa are leading the market, with significant investments in healthcare facilities and technology. The competitive landscape is characterized by a mix of local and international players, with a focus on expanding access to advanced interventional solutions. The presence of key players is gradually increasing, contributing to the overall market development in the region.

Key Players and Competitive Insights

The Interventional Radiology Products Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for minimally invasive procedures. Key players such as Medtronic (US), Boston Scientific (US), and Siemens Healthineers (DE) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through the development of advanced imaging technologies, while Boston Scientific (US) emphasizes strategic partnerships to expand its product offerings. Siemens Healthineers (DE) is leveraging digital transformation to improve operational efficiencies and patient outcomes, collectively shaping a competitive environment that prioritizes technological prowess and strategic collaborations.
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain resilience. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Cook Medical (US) and Terumo Corporation (JP) is notable, as they implement supply chain optimization strategies to maintain competitive advantages. This fragmentation allows for innovation and specialization, fostering a diverse range of products and services in the interventional radiology sector.
In August 2025, Medtronic (US) announced the launch of a new imaging system designed to enhance the precision of interventional procedures. This strategic move is significant as it aligns with the growing trend towards personalized medicine, potentially improving patient outcomes and solidifying Medtronic's position as a leader in the market. The introduction of this technology may also stimulate further innovation among competitors, as they seek to match or exceed Medtronic's advancements.
In September 2025, Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its interventional radiology products. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Boston Scientific is positioning itself to capitalize on the increasing demand for remote patient management. Such strategic alliances may enhance the company's product appeal and market reach, particularly in a post-pandemic healthcare landscape.
In July 2025, Siemens Healthineers (DE) unveiled a new AI-driven analytics platform aimed at optimizing interventional radiology workflows. This initiative reflects a growing emphasis on artificial intelligence within the industry, as companies strive to enhance operational efficiencies and improve clinical decision-making. Siemens Healthineers' investment in AI technology may not only streamline processes but also provide a competitive edge in a rapidly evolving market.
As of October 2025, current competitive trends in the Interventional Radiology Products Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is likely to evolve, shifting from traditional price-based competition to a focus on technological innovation, supply chain reliability, and enhanced patient outcomes. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the interventional radiology landscape.

Key Companies in the Interventional Radiology Products Market include

Industry Developments

Q2 2024: Boston Scientific Announces FDA Approval of Farapulse Pulsed Field Ablation System for Treatment of Atrial Fibrillation Boston Scientific received FDA approval for its Farapulse Pulsed Field Ablation System, a minimally invasive device used in interventional radiology procedures for the treatment of atrial fibrillation.
Q2 2024: Siemens Healthineers Launches Artis icono biplane, a New Interventional Imaging System Siemens Healthineers launched the Artis icono biplane, an advanced interventional radiology imaging system designed to enhance precision in minimally invasive procedures.
Q2 2024: Penumbra, Inc. Announces FDA Clearance for RED Reperfusion Catheters for Use in Mechanical Thrombectomy Penumbra, Inc. received FDA clearance for its RED Reperfusion Catheters, expanding its portfolio of devices for mechanical thrombectomy in interventional radiology.
Q3 2024: Philips Launches Azurion Neuro, an Image-Guided Therapy Platform for Neuro Interventions Philips introduced Azurion Neuro, a new image-guided therapy platform designed for neuro interventional radiology procedures, aiming to improve workflow and patient outcomes.
Q3 2024: Merit Medical Systems Announces FDA Clearance of SCOUT Bx Delivery System for Soft Tissue Biopsy Merit Medical Systems received FDA clearance for its SCOUT Bx Delivery System, a device intended to improve the accuracy and efficiency of soft tissue biopsies in interventional radiology.
Q3 2024: AngioDynamics Announces FDA Clearance of AlphaVac F18^85 Mechanical Thrombectomy System AngioDynamics received FDA clearance for its AlphaVac F18^85 Mechanical Thrombectomy System, expanding its interventional radiology product offerings for the removal of thrombus in the peripheral vasculature.
Q4 2024: Teleflex Receives FDA Clearance for Arrow VPS Rhythm DLX Device for Vascular Access Teleflex received FDA clearance for its Arrow VPS Rhythm DLX Device, designed to provide real-time tip location for vascular access procedures in interventional radiology.
Q4 2024: BD Launches UltraScore Focused Force PTA Balloon Catheter in the United States BD (Becton, Dickinson and Company) launched the UltraScore Focused Force PTA Balloon Catheter in the U.S., expanding its portfolio of interventional radiology products for peripheral artery disease treatment.
Q1 2025: Inari Medical Announces FDA Clearance of ClotTriever BOLD Catheter for Venous Thromboembolism Inari Medical received FDA clearance for its ClotTriever BOLD Catheter, a device designed for the removal of large venous clots in interventional radiology procedures.
Q1 2025: Stryker Launches Surpass Evolve Flow Diverter for Treatment of Brain Aneurysms Stryker launched the Surpass Evolve Flow Diverter, a new device for the treatment of brain aneurysms, expanding its neurointerventional radiology product line.
Q2 2025: Penumbra, Inc. Announces FDA Clearance of Lightning Flash Aspiration System for Peripheral Thrombectomy Penumbra, Inc. received FDA clearance for its Lightning Flash Aspiration System, a device designed for the removal of blood clots in peripheral vessels during interventional radiology procedures.
Q2 2025: Boston Scientific Completes Acquisition of Relievant Medsystems Boston Scientific completed the acquisition of Relievant Medsystems, expanding its interventional radiology portfolio with the addition of the Intracept Procedure for chronic vertebrogenic low back pain.

Future Outlook

Interventional Radiology Products Market Future Outlook

The Interventional Radiology Products Market is projected to grow at a 5.8% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for minimally invasive procedures, and rising healthcare expenditures.

New opportunities lie in:

Development of AI-driven imaging systems for enhanced diagnostic accuracy.
Expansion of telehealth services for remote interventional radiology consultations.
Investment in biodegradable stents to meet sustainability goals in healthcare.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

Market Segmentation

Interventional Radiology Products Market End User Outlook

Hospitals
Ambulatory Surgical Centers
Diagnostic Imaging Centers

Interventional Radiology Products Market Application Outlook

Oncology
Cardiology
Urology
Neurology

Interventional Radiology Products Market Product Type Outlook

Catheters
Guide Wires
Embolic Agents
Radiology Visualization Systems
Ablation Devices

Interventional Radiology Products Market Procedure Type Outlook

Angiography
Biliary Interventions
Biopsy
Drainage Procedures
Ablation

Report Scope

MARKET SIZE 2024	28.35(USD Billion)
MARKET SIZE 2025	30.0(USD Billion)
MARKET SIZE 2035	52.73(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.8% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), Siemens Healthineers (DE), Bayer (DE), Cook Medical (US), Terumo Corporation (JP), Philips (NL), Stryker Corporation (US)
Segments Covered	Product Type, Procedure Type, End Users, Applications, Regional
Key Market Opportunities	Advancements in minimally invasive techniques enhance growth potential in the Interventional Radiology Products Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the Interventional Radiology Products Market.
Countries Covered	North America, Europe, APAC, South America, MEA